Mission BioCapital
Venture Capital
Active
Cambridge, United States
67
40M
51
9.57
3
0.24
12
- Stages of investment
- Areas of investment
Summary
The venture was found in North America in United States. The main office of represented VC is situated in the Cambridge.
Among the most successful fund investment fields, there are Biotechnology, Medical Device. The fund has no exact preference in a number of founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight GraphWear Technologies, QurAlis, Cereius. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund.
The fund is constantly included in 2-6 deals per year. The common things for fund are deals in the range of 10 - 50 millions dollars. Speaking about the real fund results, this VC is 23 percentage points more often commits exit comparing to other organizations. The top activity for fund was in 2019.
Besides them, we counted 6 critical employees of this fund in our database.
The standard case for the fund is to invest in rounds with 3 partakers. Despite the BioInnovation Capital, startups are often financed by ic@3401, North Carolina Biotechnology Center, National Science Foundation. The meaningful sponsors for the fund in investment in the same round are Canaan Partners, Viva BioInnovator, The Engine.
Investor highlights
- Industry focus
- Stage focus
- Geo focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Last fund
- Fund size
- USD 275000000
- Fund raised date
- 2021-11-04
Analytics
- Total investments
- 67
- Lead investments
- 3
- Exits
- 12
- Rounds per year
- 9.57
- Follow on index
- 0.24
- Investments by industry
- Biotechnology (59)
- Health Care (39)
- Therapeutics (25)
- Medical (13)
- Pharmaceutical (6) Show 33 more
- Investments by region
-
- United States (65)
- Switzerland (1)
- Peak activity year
- 2019
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 7
- Avg. valuation at time of investment
- 104M
- Group Appearance index
- 0.75
- Avg. company exit year
- 4
- Avg. multiplicator
- 7.27
- Strategy success index
- 0.70
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Progentos Therapeutics | 20 May 2024 | Early Stage Venture | 65M | United States, Massachusetts, Watertown | |
| Shape Therapeutics | 06 Nov 2019 | Biotechnology | Early Stage Venture | 35M | United States, Washington, Seattle |
| Yunanbao | 29 Oct 2015 | Big Data, Cloud Computing, Cloud Security | Seed | 463K | Guangdong Province, Futian District, China |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.